All Quotes

6 quotes

FRANCIS DESOUZA

View full profile →

We took genome sequencing from $3 billion to $200. That's not cost reduction — that's a revolution.

80% of the world's DNA is read on Illumina machines. Every major genetic discovery runs on our hardware.

The Solexa acquisition for $600 million was the decision that changed everything for Illumina.

Every cancer tumor has a unique genetic signature. Sequencing that signature is how we personalize treatment.

Genome sequencing will become as routine as a blood test. That's where we're heading.

We've read more DNA than all other technologies combined. That data is priceless.